查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1585605

生物防禦市場：按產品、最終用戶分類 - 2025-2030 年全球預測

Biodefense Market by Product (Anthrax, Botulism, Radiation), End-User (Ambulatory Care Centers, Hospitals, Military) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年生物防禦市場價值為183.6億美元，預計到2024年將達到203.3億美元，複合年成長率為11.25%，到2030年將達到387.3億美元。

生物防禦涵蓋各種旨在保護人們免受病毒、細菌和其他病原體等生物製劑威脅的策略、研究和技術。這項需求源自於人們對生物武器、生物恐怖主義和自發性爆發的日益擔憂，凸顯了對強力的防禦機制的迫切需求。 Biodefense 的上市公司應用涵蓋公共衛生措施、軍事防禦戰略和醫療基礎設施，最終用途包括政府機構、醫療保健提供者、製藥公司、研究機構等。生物防禦市場的成長主要得益於研發投資的增加、政府和私營部門之間的合作以及增強早期檢測和快速反應能力的生物技術的進步。基因組定序、基於人工智慧的預測模型和疫苗開發等技術創新是關鍵機遇，投資改善生物防禦基礎設施和培訓可以進一步增強這些前景。然而，高昂的研發成本、監管障礙以及軍民兩用研究的倫理問題等挑戰構成了重大限制。此外，與生物威脅的不可預測性和複雜的地緣政治局勢相關的問題可能會使成長變得複雜。利用潛在機會的策略建議包括促進官民合作關係、增加對用於快速病原體識別的 CRISPR 等新技術的投資，以及資訊共用和資源最佳化的國際合作。此外，透過合成生物學的進步開發新治療方法和基本藥物的策略儲備都是創新的成熟領域。受地緣政治和環境變化影響的市場的動態性質需要不斷適應和發展敏捷的回應框架。透過解決這些限制並利用成長機會，相關人員可以確保有彈性和有效的生物防禦策略，為全球衛生安全和市場永續性做出重大貢獻。生物防禦不斷發展的性質要求採取積極主動的方法，結合最尖端科技並促進全球協調應對生物威脅。

主要市場統計
基準年[2023] 183.6億美元
預測年份 [2024] 203.3億美元
預測年份 [2030] 387.3億美元
複合年成長率（%） 11.25%

市場動態：揭示快速發展的生物防禦市場的關鍵市場洞察

生物防禦市場正因​​供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 存在有利的政府舉措
    • 伊波拉病毒和齊瓦病毒等各種病原體的盛行率不斷上升
    • 疾病監測的重要性日益增加
  • 市場限制因素
    • 開發中國家和低度開發國家的市場滲透率低
  • 市場機會
    • 已開發國家不斷增加的舉措
    • 生物技術的技術進步
  • 市場挑戰
    • 高時間投入和長臨床程序

波特五力：駕馭生物防禦市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物防禦市場的外部影響

外部宏觀環境因素在塑造生物防禦市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物防禦市場的競爭格局

對生物防禦市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物防禦市場供應商的績效評估

FPNV定位矩陣是評估生物防禦市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物防禦市場的成功之路

生物防禦市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 存在有利的政府舉措
      • 伊波拉病毒、齊瓦病毒等多種病原體的傳播正在加劇。
      • 疾病監測的重要性日益增加
    • 抑制因素
      • 開發中國家和最不開發中國家的市場滲透率較低
    • 機會
      • 已開發國家加強研發力度
      • 生物技術的技術進步
    • 任務
      • 大量的時間投入和漫長的臨床程序
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物防禦市場：依產品

  • 炭疽菌
  • 肉毒中毒
  • 輻射
  • 天花

第7章生物防禦市場：依最終用戶分類

  • 門診治療中心
  • 醫院
  • 軍隊
  • 調查機構

第8章美洲生物防禦市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生物防禦市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的生物防禦市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alnylam Pharmaceuticals, Inc.
  • Altimmune, Inc.
  • Bavarian Nordic A/S
  • BDO USA, LLP
  • Bharat Biotech Ltd.
  • Dynport Vaccine Company by General Dynamics Information Technology
  • Elusys Therapeutics, Inc. by Heat Biologics Inc.
  • Emergent BioSolutions Inc.
  • Evogen, Inc.
  • Ichor Medical Systems, Inc.
  • Pizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • SIGA Technologies
  • Soligenix, Inc.
  • Xoma Corporation
Product Code: MRR-434CCDA050CE

The Biodefense Market was valued at USD 18.36 billion in 2023, expected to reach USD 20.33 billion in 2024, and is projected to grow at a CAGR of 11.25%, to USD 38.73 billion by 2030.

Biodefense encompasses a range of strategies, research, and technologies aimed at protecting populations against threats from biological agents like viruses, bacteria, and other pathogens. Its necessity arises from growing concerns over biological warfare, bioterrorism, and naturally occurring outbreaks, underscoring the critical need for robust defense mechanisms. Applications of biodefense extend to public health preparedness, military defense strategies, and healthcare infrastructure, while its end-use scope includes government agencies, healthcare providers, pharmaceutical companies, and research institutions. Market growth in biodefense is primarily driven by increasing investment in R&D, collaborative efforts between government and private sectors, and advancements in biotechnology which enhance early detection and rapid response capabilities. Technological innovations such as genomic sequencing, AI-based predictive modeling, and vaccine development represent key opportunities, while investment in improving biodefense infrastructure and training can further enhance these prospects. However, challenges such as high R&D costs, regulatory hurdles, and ethical concerns over dual-use research pose significant limitations. Furthermore, issues related to the unpredictability of biological threats and the complex geopolitical landscape can complicate growth. Strategic recommendations to leverage potential opportunities include fostering public-private partnerships, increasing investment in emerging technologies like CRISPR for rapid pathogen identification, and enhancing international collaboration for information sharing and resource optimization. Exploring advancements in synthetic biology for developing novel countermeasures and strategic stockpiling of essential medical supplies are areas ripe for innovation. The market's dynamic nature, affected by geopolitical and environmental shifts, necessitates continuous adaptation and development of agile response frameworks. By addressing these limitations and capitalizing on growth opportunities, stakeholders can ensure resilient and effective biodefense strategies, making substantial contributions to global health security and market sustainability. The evolving nature of biodefense calls for a proactive approach in embracing cutting-edge technology and fostering a globally coordinated response to biological threats.

KEY MARKET STATISTICS
Base Year [2023] USD 18.36 billion
Estimated Year [2024] USD 20.33 billion
Forecast Year [2030] USD 38.73 billion
CAGR (%) 11.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biodefense Market

The Biodefense Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Presence of favorable government initiatives
    • Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
    • Increasing importance of disease surveillance
  • Market Restraints
    • Low market penetration in developing and underdeveloped countries
  • Market Opportunities
    • Rising initiatives for research & developments in developed countries
    • Technological advancement in biotechnology
  • Market Challenges
    • High time investment and longer clinical procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biodefense Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biodefense Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biodefense Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biodefense Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biodefense Market

A detailed market share analysis in the Biodefense Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biodefense Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biodefense Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biodefense Market

A strategic analysis of the Biodefense Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biodefense Market, highlighting leading vendors and their innovative profiles. These include Alnylam Pharmaceuticals, Inc., Altimmune, Inc., Bavarian Nordic A/S, BDO USA, LLP, Bharat Biotech Ltd., Dynport Vaccine Company by General Dynamics Information Technology, Elusys Therapeutics, Inc. by Heat Biologics Inc., Emergent BioSolutions Inc., Evogen, Inc., Ichor Medical Systems, Inc., Pizer Inc., Serum Institute of India Pvt. Ltd., SIGA Technologies, Soligenix, Inc., and Xoma Corporation.

Market Segmentation & Coverage

This research report categorizes the Biodefense Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Anthrax, Botulism, Radiation, and Small Pox.
  • Based on End-User, market is studied across Ambulatory Care Centers, Hospitals, Military, and Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Presence of favorable government initiatives
      • 5.1.1.2. Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
      • 5.1.1.3. Increasing importance of disease surveillance
    • 5.1.2. Restraints
      • 5.1.2.1. Low market penetration in developing and underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising initiatives for research & developments in developed countries
      • 5.1.3.2. Technological advancement in biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. High time investment and longer clinical procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biodefense Market, by Product

  • 6.1. Introduction
  • 6.2. Anthrax
  • 6.3. Botulism
  • 6.4. Radiation
  • 6.5. Small Pox

7. Biodefense Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Care Centers
  • 7.3. Hospitals
  • 7.4. Military
  • 7.5. Research Organizations

8. Americas Biodefense Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biodefense Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biodefense Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alnylam Pharmaceuticals, Inc.
  • 2. Altimmune, Inc.
  • 3. Bavarian Nordic A/S
  • 4. BDO USA, LLP
  • 5. Bharat Biotech Ltd.
  • 6. Dynport Vaccine Company by General Dynamics Information Technology
  • 7. Elusys Therapeutics, Inc. by Heat Biologics Inc.
  • 8. Emergent BioSolutions Inc.
  • 9. Evogen, Inc.
  • 10. Ichor Medical Systems, Inc.
  • 11. Pizer Inc.
  • 12. Serum Institute of India Pvt. Ltd.
  • 13. SIGA Technologies
  • 14. Soligenix, Inc.
  • 15. Xoma Corporation

LIST OF FIGURES

  • FIGURE 1. BIODEFENSE MARKET RESEARCH PROCESS
  • FIGURE 2. BIODEFENSE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIODEFENSE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIODEFENSE MARKET DYNAMICS
  • TABLE 7. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIODEFENSE MARKET SIZE, BY RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIODEFENSE MARKET SIZE, BY SMALL POX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIODEFENSE MARKET SIZE, BY MILITARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2023